TP53 and familial pancreatic carcinoma: In conclusion, our study demonstrated that the TP53 codon 72 polymorphism is potentially a genetic predisposing factor for pancreatic cancer and MDM2 SNP 309 polymorphism might be useful for predicting survival outcome in PDAC patients.